Redefining brain and mental health care through neurotechnologies – from Alzheimer’s to stroke, from Obsessive Compulsive Disorder to depression –, is the declared goal of the new Digital Neurotherapeutics Centre (DNTx), which opened its doors to the public at the Champalimaud Foundation (CF) on May 18th.

To know more about this research:

The Open Labs are where scientific research comes to life at the Champalimaud Foundation.

Filled every day with scientists discussing ideas, testing setups, analysing data and challenging assumptions, these spaces thrive on curiosity, collaboration and discovery.

Here, questions are encouraged. Experiments are tested, sometimes fail, and are then rethought, refined and repeated, transforming uncertainty into knowledge.

With a career spanning leadership of some of Europe’s most influential biomedical research institutions, Otmar Wiestler joins the Champalimaud Foundation as Director of Champalimaud Science. An internationally recognised physician-scientist and research leader, he has played a central role in shaping large-scale scientific organisations, most notably as President of the Helmholtz Association and, prior to that, as Chairman and CEO of the German Cancer Research Center (DKFZ).